Non-small cell lung cancer (NSCLC) constitutes a healthcare problem because of its incidence, mortality, and the burden of symptoms that it produces. Therefore, treatment goals include symptom control and maintenance of quality of life (QoL). However, QoL is not fully evaluated in clinical practice. The higher acceptance of wearables technology enables to automatically monitor health parameters. Sensors from smartphones allow continuous quantification of parameters regarding QoL along with patient reported outcomes measures (PROMs) using a single app. Our objective is to assess the feasibility of using smartphone sensors and self-registering PROMs through the app Lalaby® in outpatients with NSCLC receiving systemic treatment.
You can access the paper here:
Soria-Comes, T., et al. «EP10. 01-017 Use of Lalaby in Lung Cancer Patients to Trace Performance from Phone Sensors and Reported Outcomes Involving Quality of Life.» Journal of Thoracic Oncology 17.9 (2022): S507-S508. https://doi.org/10.1016/j.jtho.2022.07.894
